Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Nuclear Cardiology"
DOI: 10.1007/s12350-019-01977-5
Abstract: Some studies report that assessing regional 123I-cardiac MIBG uptake can aid in the diagnosis of Lewy body disease, but others report heterogeneity in healthy controls. We aimed to evaluate regional cardiac MIBG uptake patterns in…
read more here.
Keywords:
adults normal;
mibg uptake;
cardiac 123i;
patients dementia ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Neuroscience Letters"
DOI: 10.1016/j.neulet.2021.136399
Abstract: Cardiac 123I-metaiodobenzylguanidine (MIBG) uptake correlates with the extent of cardiac sympathetic denervation found in disease with Lewy pathology, such as Parkinson's disease (PD). Protein α-synuclein, the main component of Lewy body, is a candidate biomarker…
read more here.
Keywords:
mibg;
synuclein;
parkinson disease;
plasma synuclein ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001581
Abstract: Purpose Some studies have suggested that cardiac [123I]metaiodobenzylguanidine images obtained 15–20 min after tracer administration are as accurate for dementia with Lewy bodies (DLB) diagnosis as standard images acquired after a delay of 3–4 h; some suggest…
read more here.
Keywords:
123i mibg;
early phase;
early delayed;
phase cardiac ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15060656
Abstract: Cardiac sympathetic upregulation is one of the neurohormonal compensation mechanisms that play an important role in the pathogenesis of chronic heart failure (CHF). In the past decades, cardiac 123I-mIBG scintigraphy has been established as a…
read more here.
Keywords:
123i mibg;
heart failure;
cardiac 123i;
chf ... See more keywords